Delivery Order SPE2DB22D1103-SPE2DB25FTPM0
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $47,839.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,956,447 tablets of the medication Dasatinib 70 mg. The contract is a firm fixed-price agreement with an ultimate completion date of April 18, 2025. This contract is not set aside for any specific business category. Amerisourcebergen Drug...
This federal contract award, valued at $5,456.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568096600 - Dasatinib 20 mg Tablet 60s, a prescription medication, with a completion date of May 2, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,632.41, is for the delivery of the medication Dasatinib 100 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $22,158.12 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Dasatinib 50 mg tablets, a medication used to treat certain types of cancer. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA to provide a...
This federal contract award, valued at $11,177.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of DASATINIB 100 MG TABLET 30S, a pharmaceutical product, and has a completion date of June 4, 2025. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of DASATINIB 100 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a Firm Fixed Price Delivery Order with a ceiling value of $11,697.68. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a $6,653.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DASATINIB 70 MG TABLET 60S, a prescription medication. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 60-count tablets of the medication Sprycel (dasatinib) 50 mg. The contract has a ceiling value of $9,692.86 and runs through August 30, 2024. It is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, will...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,322.18 fixed-price delivery order is for SPRYCEL 100 MG TABLET 30S, a specialty medication, with a completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award, valued at $30,962.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Sprycel 50 mg tablets. This contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. The contract has an ultimate completion...